Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for ZNTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 71.67M
March 31, 2026 71.16M
December 31, 2025 69.09M
September 30, 2025 72.25M
June 30, 2025 72.14M
March 31, 2025 71.95M
December 31, 2024 71.28M
September 30, 2024 71.15M
June 30, 2024 71.11M
March 31, 2024 71.01M
December 31, 2023 70.77M
September 30, 2023 70.64M
June 30, 2023 70.60M
March 31, 2023 59.44M
December 31, 2022 59.28M
Date Value
September 30, 2022 57.00M
June 30, 2022 56.97M
March 31, 2022 45.58M
December 31, 2021 45.49M
September 30, 2021 45.20M
June 30, 2021 41.31M
March 31, 2021 41.04M
December 31, 2020 41.04M
September 30, 2020 40.61M
June 30, 2020 35.88M
March 31, 2020 35.88M
December 31, 2019 35.88M
September 30, 2019 5.601M
June 30, 2019 35.88M
March 31, 2019 35.88M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
ARS Pharmaceuticals, Inc. 99.44M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M
Anika Therapeutics, Inc. 13.38M
Savara, Inc. 205.40M